Li J, Wang L, Lu Y, Zhou Y, et al. Nafamostat mesylate versus regional citrate anticoagulation for chronic hemodialysis in patients at high risk of bleeding: a single-center, retrospective study. Ren Fail 2025;47:2464830.
PMID: 39980305